About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Independent Consultant/Advisor, Lead SME, GCC Consultant/advisor, Startup Mgmt. Consultant, Advisor (Nov 2025 - Present); India
The article explores the evolution of pharma Global Capability Centers, highlighting their shift from cost-saving to innovation, the impact of AI and compliance, and the growing importance of talent and decision rights.
Zonal Sales Manager (Jan 2026 - Present); India
An industry expert shares on-the-ground insights on regulatory changes, hospital procurement, AI-driven engagement, and supply challenges shaping India’s pharmaceutical and healthcare landscape.
Founding Scientist
Digital twins can prevent $2M failed batches and help pharma companies avoid $50–$200M revenue risks from regulatory issues. Read the full article to learn how digital twins provide solutions.
Head of Marketing (Dec 2014 – Present)
Pharma’s shift to data-driven commercialization is reshaping decisions amid rising compliance, pricing, and ESG pressures. While AI shows selective gains, ROI gaps persist, exposing value chain vulnerabilities and execution challenges in high-growth segments.
Regional Vice President (Dec 2024 – Present)
Structural shifts in healthcare revenue cycle management are reshaping tech adoption, while automation ROI, regulatory constraints, and operational complexity determine scalability, revealing underpenetrated opportunities across provider segments and administrative ecosystems.
Founder & Director at Zantus Lifesciences (Apr 2025 – Present); India
AI-driven, end-to-end integration across R&D, manufacturing, and supply chains is reshaping life sciences leadership. Decisive now due to margin pressure and regulatory complexity, returns hinge on execution, compliance trade-offs, and fragile global supply nodes.